Lemtrada Patients Could Be At Risk When Taking Covid-19 Vaccine

Lemtrada Stroke Lawsuit News

The Covid-19 vaccine will be offered to the public by age, and people taking Lemtrada should first consult their doctor

Tuesday, December 15, 2020 - Lemtrada (alemtuzumab) is a highly-effective, yet risky, treatment for relapse-remitting multiple sclerosis (RRMS). Lemtrada is considered a drug of last resort and should be attempted only when two or more disease-modifying therapies (DMT) have been tried and failed. In 2018, the Food and Drug Administration ordered Lemtrada's safety profile to be updated after complaints were made to the government via the Federal Adverse Event Reporting System. Lemtrada patients have been reported to have died from a heart attack or a stroke within the first 72 hours after initially receiving the drug. Many were not warned of the life-threatening side effects in advance and thus were denied their right to make an informed decision. Many have hired a Lemtrada Stroke Lawyer to help them sort things out and file a claim against Sanofi, the maker of Lemtrada.

People with relapse-remitting multiple sclerosis and currently undergoing a disease-modifying therapy like Lemtrada infusion are concerned that there may be complications in taking Pfizer's Covid-19 vaccine. RRMS patients could be among those considered most vulnerable and eligible for early vaccination. Age, however, according to MS Trust will be the overriding factor in deciding who gets the vaccine first. It is generally accepted that the older you are, the more severe the symptoms of Covid-19 could be, and the greater the risk to one's life. Obesity is another factor to consider as are people with a pre-existing life-threatening illness like cancer or heart disease. Individuals over 85 and in nursing home care will get the vaccine first, followed by everyone else in five-year increments down to age 50. First responders, school teachers, and transportation workers will also have priority in receiving the vaccine. Multiple Sclerosis Trust offers guidance for people with RRMS that fall into the age category of those who will receive the vaccine first.

Doctors believe that RRMS sufferers should not worry about taking the vaccine, however, those on disease-modifying drugs, especially those such as Lemtrada, should consult their RRMS doctors immediately as the interactions between drugs are uncertain. MST stated the following: "Having MS by itself does not mean that you shouldn't take the vaccine. There's no concern that a vaccine will cause MS, trigger a relapse, or make your symptoms worse. I would encourage everyone with MS to look forward to taking this vaccine unless they're told that they shouldn't have it because of the drugs they're on. There are some disease-modifying drugs (DMD) that are used to treat MS which would make some vaccines either unsafe or ineffective."

If you or a loved one are on Lemtrada and have suffered a stroke or heart attack you might consider consulting a Lemtrada Stroke attorney to see if you qualify to file a claim. The severe, life-threatening side effects of stroke and arterial dissection were only made public by the company many years after the drug was placed on the market, and only after the FDA pressed Sanofi to update their warning label in 2018.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.